General Archive

-
News releasesLifeArc backs major study of 80,000 blood samples to advance research into Parkinson’s, Alzheimer’s and rare dementias
We’re funding a major new study, alongside Alzheimer’s Research UK and The Michael J. Fox Foundation, that will analyse more…
-
News releasesCould an existing antibiotic be used to treat rare liver disease?
A new international clinical trial funded by medical research organisation LifeArc will test whether oral vancomycin, an existing antibiotic, could…
-
News releasesCelebrating 2 years of the network driving innovation for people with CF
This month marks 2 years of the Translational Innovation Hub Network for Cystic Fibrosis Lung Health and Infection, the CF…
-
ArticlesWhat makes cystic fibrosis research such a rewarding career?
Over the last decade, advances in treatments have transformed outcomes for many people living with cystic fibrosis (CF). But significant…
-
News releasesIntroducing Raremap: a new way to navigate the rare disease landscape
LifeArc has collaborated with Rare Disease Research UK to launch Raremap, the UK’s first directory of rare disease organisations. There’s a vibrant…
-
News releasesLifeArc-founded RQ Bio secures £85.5 million to advance long-acting antibody for influenza prevention
The LifeArc-founded and backed biotech company RQ Bio has this week announced the completion of an oversubscribed $115 million (£85.5…
-
News releasesNew boost for personalised rare disease treatments as the Rare Therapies Launch Pad becomes part of LifeArc
We will be integrating the Rare Therapies Launch Pad (RTLP) into our organisation, marking an important next step in efforts…
-
News releasesWorld-first gene therapy to target devastating rare immune disorder
A first-of-its-kind gene therapy to treat people with CTLA-4 insufficiency, a rare and life-limiting inherited immune disorder, is being advanced…
-
News releasesLifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children
We have announced a new partnership with Elpida Therapeutics to support the development of three gene therapy programmes targeting ultra-rare…
-
BlogsFrom curiosity to career: LifeArc placement students share their stories for British Science Week
Curiosity is where every scientific journey begins. To celebrate British Science Week and this year’s theme of curiosity, we’re passing the…
-
News releasesFirst projects backed by C-Further consortium to develop better treatments for children with cancer
Children and young people diagnosed with aggressive cancers could benefit from potential new treatments from two pioneering projects led by…
-
News releasesFirst‑of‑its‑kind UK data initiative to boost early diagnosis and deliver better treatments for children with rare diseases
We are joining forces with Great Ormond Street Hospital (GOSH) on a data initiative – KidsRare – with the aim…
